This site is new - feedback and suggestions welcome via GitHub issues.

#glycemic control — Sunday, June 07, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study. (linkinghub.elsevier.com) robot Rosenstock J … Jain AB The Lancet 2026-06-07 #clinical trial #diabetes #pharmacotherapy #glycemic control #insulin